Literature DB >> 1552212

Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection.

J M Durand, G Kaplanski, P Lefevre, M A Richard, L Andrac, C Trepo, J Soubeyrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1552212     DOI： 10.1093/infdis/165.4.778

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Is interferon alpha 2b effective on cryoglobulinaemia related to hepatitis C virus?

Authors:  B Taillan; E Ferrari; A Pesce; G Garnier; H Vinti; J G Fuzibet; P Dujardin
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

2.  Managing chronic hepatitis C virus infection.

Authors:  J Y Lau; G L Davis
Journal:  BMJ       Date:  1993-02-20

Review 3.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia.

Authors:  G Kaplanski; V Marin; T Maisonobe; A Sbai; C Farnarier; P Ghillani; X Thirion; J M Durand; J R Harlé; P Bongrand; J C Piette; P Cacoub
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection.

Authors:  J M Durand; E Cretel; G Kaplanski; P Lefevre; F Retornaz; J Soubeyrand
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

6.  Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.

Authors:  V M Lauta; M A De Sangro
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

Review 7.  A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha.

Authors:  C A Schirren; R Zachoval; C G Schirren; A L Gerbes; G R Pape
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.